drugset / Trial / NCT01390961

Comparison of Tolerability Between Two Allergy Drops

NCT01390961

Phase 4 Unknown 48 enrolled Hom, Milton M., OD, FAAO Allergan · collab
RandomizedCrossoverSingle-blindTreatment

Summary

Comfort is compared between two allergy drops

Timeline

Start
2011-08
Primary completion
2011-12
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Naphazoline Small molecule
Subject alacaftadine Unknown
Subject pheniramine Small molecule

Indications